↓ Skip to main content

Health-related quality of life in survivors of stage I-II breast cancer: randomized trial of post-operative conventional radiotherapy and hypofractionated tomotherapy

Overview of attention for article published in BMC Cancer, October 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 tweeter

Readers on

mendeley
101 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Health-related quality of life in survivors of stage I-II breast cancer: randomized trial of post-operative conventional radiotherapy and hypofractionated tomotherapy
Published in
BMC Cancer, October 2012
DOI 10.1186/1471-2407-12-495
Pubmed ID
Authors

Harijati Versmessen, Vincent Vinh-Hung, Hilde Van Parijs, Geertje Miedema, Mia Voordeckers, Nele Adriaenssens, Guy Storme, Mark De Ridder

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 101 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 2 2%
Colombia 1 <1%
Slovenia 1 <1%
Unknown 97 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 22 22%
Researcher 19 19%
Student > Ph. D. Student 10 10%
Other 7 7%
Student > Postgraduate 7 7%
Other 21 21%
Unknown 15 15%
Readers by discipline Count As %
Medicine and Dentistry 40 40%
Nursing and Health Professions 14 14%
Psychology 9 9%
Sports and Recreations 3 3%
Physics and Astronomy 3 3%
Other 14 14%
Unknown 18 18%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 December 2015.
All research outputs
#7,762,243
of 12,372,945 outputs
Outputs from BMC Cancer
#2,225
of 4,558 outputs
Outputs of similar age
#172,300
of 333,332 outputs
Outputs of similar age from BMC Cancer
#333
of 725 outputs
Altmetric has tracked 12,372,945 research outputs across all sources so far. This one is in the 23rd percentile – i.e., 23% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,558 research outputs from this source. They receive a mean Attention Score of 3.9. This one is in the 40th percentile – i.e., 40% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 333,332 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 725 others from the same source and published within six weeks on either side of this one. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.